litapiprant (HEC46877)
/ Sunshine Lake Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 27, 2020
The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
(clinicaltrials.gov)
- P1; N=60; Completed; Sponsor: Sunshine Lake Pharma Co., Ltd.; Recruiting ➔ Completed
Clinical • Trial completion • Asthma • Respiratory Diseases
1 to 1
Of
1
Go to page
1